UnitedHealth Just Raised Guidance for the Third Time This Year. Where Will the Stock Be in 3 Years?

UnitedHealth (UNH) has raised its 2026 adjusted EPS guidance for the third time this year, lifting the target to $20.50 from $17.75 in January. That is a $2.75 increase, or roughly 15.5% above the initial outlook, delivered in three steps rather than one.

The source attributes the momentum to two drivers: operational improvements in Optum Health and better medical cost management. Medical costs have been the central pressure point for the stock, so repeated upward revisions suggest management is gaining control of that line. That is interpretation, not a reported finding.

Looking further out, analysts project UNH could reach between $444 and $672 by 2029, assuming 13-16% annual earnings growth. The wide spread, a gap of $228 per share between the low and high ends, shows how sensitive the long-term outlook is to whether that growth rate holds.

The risks remain explicit. Regulatory scrutiny and rising medical costs could derail the turnaround narrative. Interpretation: a company that has already guided up three times has raised the bar for itself, so any stumble on cost trends would likely hit harder than it would have at the January guidance level.